• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Section Contents Menu

Enforcement Actions

-
 

2003 Warning Letters

-

Recently Posted | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |

Tobacco Retailer Warning Letters

 

-

Recently Posted | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2003

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

 
Letter Issue Date Company Name Issuing Office Subject Close Out Date
March 21, 2003 Medical Associates Health Center Minneapolis District Office Mammography Quality Standards N/A *
March 21, 2003 International Association for Colon Hydrotherapy Center for Devices and Radiological Health Sponsor Obligations N/A *
March 21, 2003 Rx Depot Inc Center for Drug Evaluation and Research Illegal Canadian Drug Importation N/A *
March 21, 2003 Laureano Gerardo Flores Dallas District Office Circumvention of Import Alert/Misleading Labeling/Misbranded N/A *
March 21, 2003 Georg Leibinger Center for Devices and Radiological Health Lacks Premarket Approval/QSR/Not Substantially Equivalent/Adulterated/Misbranded N/A *
March 20, 2003 Imperial Chef's Food, Inc. Los Angeles District Office Seafood HACCP/Adulterated N/A *
March 20, 2003 Ricky A. Ellis Atlanta District Office Edible Tissue/Adulterated N/A *
March 20, 2003 Baltimore Imaging Centers Baltimore District Office Mammography Quality Standards N/A *
March 19, 2003 Diagnostic Imaging of Clifton, P.A. New Jersey District Office Mammography Quality Standards N/A *
March 18, 2003 Warner Chilcott, Inc New Jersey District Office Postmarketing Adverse Drug Experience Reporting Requirements N/A *
March 18, 2003 Laurel Diagnostic Imaging Baltimore District Office Mammography Quality Standards N/A *
March 18, 2003 A Spicy World Company New Orleans District Office Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Human Food/Adulterated N/A *
March 18, 2003 Mary's Malasadas, Inc. San Francisco District Office Color Additive Undeclared/Misbranded N/A *
March 17, 2003 Talbert, Timothy M., M.D. Center for Devices and Radiological Health Clinical Investigator N/A *
March 17, 2003 Diethrich, Edward B., M.D. Center for Devices and Radiological Health Clinical Investigator N/A *
March 14, 2003 Syntho Pharmaceuticals, Inc. New York District Office CGMP for Finished Pharmaceuticals/CGMP in Manufacturing, Processing, Packing, or Holding/Adulterated N/A *
March 14, 2003 Alvieira Dairy Seattle District Office Illegal Drug Tissue Residue/Adulterated N/A *
March 14, 2003 Syntho Pharmaceuticals New York District Office Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated N/A *
March 13, 2003 Healthsouth Diagnostic Center of Fayetteville Atlanta District Office Mammography Quality Standards N/A *
March 13, 2003 U.S. Apothecary Labs Inc Los Angeles District Office New Drug/Misbranded N/A *



-
 

Contact FDA

ICECI Warning Letters

Division of Freedom of Information (HFI-35)

Food and Drug Administration

5600 Fishers Lane

Rockville, MD 20857
-
-
-
-